Top Markets
Coin of the day
Baudax Bio, Inc. Baudax Bio, Inc.

Baudax Bio, Inc.

BXRXQ
Clasificación en acciones #42133
Baudax Bio, Inc., a biotechnology company, develops and commercializes products... Baudax Bio, Inc., a biotechnology company, develops and commercializes products for hospital and other acute care related settings. The company develops T cell receptor, that focus on immune modulating therapies for orphan diseases or complications associated with such diseases, as well as the treatment of autoimmune disorders. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2015 and is based in Malvern, Pennsylvania. On February 22, 2024, Baudax Bio, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Pennsylvania.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$4.36K
Cambio (1 día)
0.00%
Cambio (1 año)
9,900.00%
País
US
Comercio Baudax Bio, Inc. (BXRXQ)

Categoría

EPS de Baudax Bio, Inc. (BXRXQ)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Baudax Bio, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Baudax Bio, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
$13.70 -
BE
- -
KR